Feature|Articles|September 12, 2023
- Pharmaceutical Executive: September 2023
- Volume 43
- Issue 9
Pharmaceutical Executive, September 2023 Issue (PDF)
Advertisement
Articles in this issue
over 2 years ago
A New Era of Ethical Leadershipover 2 years ago
Survival Story: Enhertuover 2 years ago
Gut Instinct: Rebyotaover 2 years ago
Delaying Disease Onset: Tzieldover 2 years ago
New Beginnings: Sunlencaover 2 years ago
A Heartfelt Solution: Camzyosalmost 3 years ago
Fortifying Defenses Pre-Patent Cliffalmost 3 years ago
New Product Planning: The Function's Evolution in Pharmaalmost 3 years ago
No Rate Relief in Sight for BiotechAdvertisement
Advertisement
Advertisement
Trending on PharmExec
1
Beyond JAK Inhibitors: Biologics Signal a New Era in Alopecia Areata
2
Pharma M&A Roundup: Incyte to Acquire Vega Therapeutics, Galmed Pharmaceuticals to Acquire Colospan, Johnson & Johnson Acquires Firefly Bio
3
Chai Discovery Enters License Agreement with Pfizer to Accelerate Drug Discovery with AI
4
U.S. Supreme Court Unanimously Votes in Favor of Hikma in Case Against Amarin: Report
5